Spectre Acquisition Corp (SPEX)
| Market Cap | 77.30M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 7.73M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About SPEX
Spectre Acquisition is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. [Read more]
News
Spectre Acquisition IPO Registration Document (S-1)
Spectre Acquisition has filed to go public with an IPO on the NASDAQ.
SPAC Spectre Acquisition files for a $60 million IPO, led by Chinese executives
Spectre Acquisition, a blank check company led by Chinese executives, filed on Wednesday with the SEC to raise up to $60 million in an initial public offering.
As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Continued Unmet Needs and Track New Launches
Spherix Global Insights releases market landscape evolution study paired with new research tracking familiarity and uptake of Novartis' Fabhalta and Alexion/AstraZeneca's Voydeya. Spherix Global Insig...
Spherix Global Insights Appoints Leigh Anne Siino as Chief Revenue Officer
Leigh Anne Siino joins executive team to accelerate company's revenue growth. Leigh Anne Siino joins executive team to accelerate company's revenue growth.
Spherix Global Insights Expands Therapeutic Area Coverage into Hematology
Spherix diversifies portfolio with strategic entry into classical hematology, tapping into a specialty with a high unmet patient need and expansive market growth. Spherix diversifies portfolio with st...
Spherix Global Insights Partners With Content Catalyst to Launch Best-in-class Client Portal
CAMBRIDGE, England--(BUSINESS WIRE)-- #analyst--Spherix Global Insights partners with specialist technology provider Content Catalyst to deploy their advanced portal for clients to interact with Spher...
Monroe Capital Supports Susquehanna Private Capital's Acquisition of Spherix Global Insights
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) today announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of...
Takeda's Entyvio SC and Celltrion's Remsima SC EU5 Launches Have Benefitted from Parent Brand Reputation, New Clinical Data, and COVID-19 Restraints, According to Spherix Global Insights
EXTON, Pa., Jan. 20, 2021 /PRNewswire/ -- Two 2020 European Medical Agency (EMA) approvals, Takeda's Entyvio SC and Celltrion Healthcare's infliximab biosimilar, Remsima SC, have captured notable shar...
Increased Biosimilar Prescribing and New Subcutaneous Formulations Are Poised to Impact Biologic Switching in the EU Inflammatory Bowel Disease Market, According to Spherix Global Insights
EXTON, Pa., Nov. 9, 2020 /PRNewswire/ -- According to the latest report published as part of Spherix's RealWorld Dynamix™: Biologic/Small Molecule Switching in IBD (EU) service, EU gastroenterologists...
Recent, Positive Efficacy Data for Janssen's Stelara in Refractory Crohn's Disease Significantly Boost Patient Share for the IL-12/23 Inhibitor, According to Spherix Global Insights
EXTON, Pa., Sept. 9, 2020 /PRNewswire/ -- According to the latest report published as part of Spherix's RealTime Dynamix™: Inflammatory Bowel Disease US service, gastroenterologists (n=100) continue t...
SGLT2 Inhibitors Could Induce a Seismic Shift in Treatment of Diabetic Kidney Disease in the US, According to Spherix Global Insights
EXTON, Pa., Sept. 8, 2020 /PRNewswire/ -- With the increasing prevalence of diabetes across the United States, concern about diabetic kidney disease (DKD) remains high among nephrologists, who consist...
3 Biotech Stocks Defying Today's Market Meltdown Thanks To COVID-19 Developments
The major U.S. stock market averages were all tumbling close to 5% and bond yields were hitting record lows Monday following oil's plunge in the wake of the wrangling between Saudi Arabia and Russia.
4 Biotech Stocks Moving On COVID-19 Updates
The COVID-19 outbreak has proved to be a catalyst for biotechs. Some issues that were wallowing in penny stock territory have posted stratospheric gains in the wake of efforts to develop diagnostic te...
Spherix stock soars after option executed for technology in patent for methods to treat coronavirus infection
Shares of Spherix Inc. spex soared 21% in active morning trading Friday.
Emerging Markets Report: In the Money
An Emerging Markets News Commentary
Emerging Markets Report: Botox, Anthrax, and the Healing Power of Poison
An Emerging Markets News Commentary
4 Stocks Join Ben Graham Net-Net Screener Friday
Year to date, the market has gifted investors a 9.92% return, but it remains off 5.73% from the start of the fourth quarter. While many investors are enjoying a lift in their stocks, the Ben Graham Sc...